~5 years of efficacy & safety data for DARZALEX® + Rd in newly diagnosed, transplant-ineligible patients1,2
The science behind DARZALEX FASPRO® and DARZALEX®
Administering DARZALEX FASPRO®
and DARZALEX®
Resources for your practice to help your patients
Tap into education and guidance to support you and your patients along the treatment journey
Patient brochure
Educates patients on multiple myeloma and treatment with DARZALEX FASPRO®
Dosing calendar
Helps patients stay on track with their DARZALEX FASPRO® treatment regimen
DARZALEX FASPRO® doctor conversation guide
Assists patients with preparing questions for their doctor about DARZALEX FASPRO®
DARZALEX® personalized doctor conversation starter
Allows patients to choose questions about DARZALEX® to discuss with their doctor
Patient education and support program
Provides one-on-one guidance, information, and education to help patients start and stay on treatment
Patient support organizations
Provide education, resources, and research for patients with multiple myeloma
DARZALEX FASPRO® MOA video
Explains the science behind daratumumab and hyaluronidase, the active ingredients in DARZALEX FASPRO®
DARZALEX® MOA video
Explains how daratumumab, the active ingredient in DARZALEX®, works in the body
Dosing and administration guide
Provides step-by-step instructions on how to administer DARZALEX FASPRO® and DARZALEX®
Dosing and administration video
Demonstrates how to administer an injection of DARZALEX FASPRO®
DRd=DARZALEX® (D) + lenalidomide (R) + dexamethasone (d); MOA=mechanism of action; Rd=lenalidomide (R) + dexamethasone (d).